These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16849416)

  • 1. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
    Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
    Goodarzi MO; Antoine HJ; Azziz R
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
    Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
    Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
    Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
    Xu N; Taylor KD; Azziz R; Goodarzi MO
    Fertil Steril; 2010 Jun; 94(1):255-60.e1-2. PubMed ID: 19327767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5alpha-reductase activity in women with polycystic ovary syndrome.
    Jakimiuk AJ; Weitsman SR; Magoffin DA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2414-8. PubMed ID: 10404813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
    Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic hirsutism: local and peripheral expression of aromatase (CYP19A) and 5α-reductase genes (SRD5A1 and SRD5A2).
    Caglayan AO; Dundar M; Tanriverdi F; Baysal NA; Unluhizarci K; Ozkul Y; Borlu M; Batukan C; Kelestimur F
    Fertil Steril; 2011 Aug; 96(2):479-82. PubMed ID: 21676395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First evidence of genetic association between AKT2 and polycystic ovary syndrome.
    Goodarzi MO; Jones MR; Chen YD; Azziz R
    Diabetes Care; 2008 Dec; 31(12):2284-7. PubMed ID: 18768676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.
    Shah NA; Antoine HJ; Pall M; Taylor KD; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2008 May; 93(5):1939-45. PubMed ID: 18303071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
    Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
    Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of male pattern baldness and the 5alpha-reductase genes.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 1998 Jun; 110(6):849-53. PubMed ID: 9620288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.
    Eriksen MB; Brusgaard K; Andersen M; Tan Q; Altinok ML; Gaster M; Glintborg D
    Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):39-42. PubMed ID: 22504079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
    Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
    Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.